KCNA3 and Alzheimer disease: Recently, the use of fampridine, a potassium channel blocker, in individuals with multiple sclerosis appeared to be beneficial in improving gait speed [38], while memantine, an anti-dementia drug, was able to improve gait variability in patients diagnosed with Alzheimer’s disease (AD) [36].